United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,334,700 | 1,195,100 | 984,800 | 727,300 | 475,800 |
| Depreciation Amortization | 85,600 | 72,500 | 53,200 | 51,300 | 49,900 |
| Income taxes - deferred | 97,700 | -64,100 | -64,400 | N/A | N/A |
| Accounts receivable | -70,900 | -400 | -58,500 | -21,700 | -41,300 |
| Accounts payable and accrued liabilities | 97,900 | 42,700 | 57,100 | 44,500 | -12,500 |
| Other Working Capital | -106,500 | 3,900 | -33,400 | -141,200 | -174,200 |
| Other Operating Activity | 122,700 | 77,400 | 39,200 | 142,300 | 300,500 |
| Operating Cash Flow | $1,561,200 | $1,327,100 | $978,000 | $802,500 | $598,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,598,800 | -844,800 | -2,514,300 | -1,706,300 | -1,736,200 |
| PPE Investments | -520,500 | -246,500 | -230,400 | -138,800 | -120,800 |
| Net Acquisitions | N/A | N/A | -89,200 | N/A | N/A |
| Purchase Of Investment | -10,400 | -28,500 | -23,000 | 0 | 0 |
| Sale Of Investment | 1,583,900 | 1,537,000 | 2,137,300 | 1,030,100 | 1,370,100 |
| Purchase Sale Intangibles | -5,500 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -5,500 | 0 | 0 | 3,500 | 0 |
| Investing Cash Flow | $-551,300 | $417,200 | $-719,600 | $-811,500 | $-486,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200,000 | 0 | 0 | 800,000 | 0 |
| Common Stock Issued | 183,100 | 160,100 | 104,600 | 94,300 | 55,600 |
| Common Stock Repurchased | -1,016,600 | -1,012,200 | -13,800 | -11,400 | -10,800 |
| Other Financing Activity | -516,500 | -402,700 | -102,700 | -807,500 | 0 |
| Financing Cash Flow | $-1,150,000 | $-1,254,800 | $-11,900 | $75,400 | $44,800 |
| Beginning Cash Position | 1,697,200 | 1,207,700 | 961,200 | 894,800 | 738,700 |
| End Cash Position | 1,557,100 | 1,697,200 | 1,207,700 | 961,200 | 894,800 |
| Net Cash Flow | $-140,100 | $489,500 | $246,500 | $66,400 | $156,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,561,200 | 1,327,100 | 978,000 | 802,500 | 598,200 |
| Capital Expenditure | -520,500 | -246,500 | -230,400 | -138,800 | -120,800 |
| Free Cash Flow | 1,040,700 | 1,080,600 | 747,600 | 663,700 | 477,400 |